Apitoria Pharma Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Unit-IV, Sy.No's.52,53,58,59,61 to 78,127&128, Pydibhimavaram V & Sy.No 1,2,4to9,11,29,30,31&32, Chittivalasa V, Ranasthalam Mandal, Srikakulam, Andhra Pradesh 532409, India (IND)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3004611182 · DUNS 918917626
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2022-08-02
- OAIDrug Quality Assurance2019-02-09
- NAIDrug Quality Assurance2017-02-21
- NAIDrug Quality Assurance2015-04-30
- VAIDrug Quality Assurance2012-06-08
- NAIDrug Quality Assurance2009-10-22
Drugs this plant is listed as making
2 distinct drugs across 3 products name this site in their FDA label.
- Ibandronate SodiumEugia US LLC
- LevofloxacinEugia US LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.